FDA Inspection 1093480 — Blood Bank Of Hawaii

Blood Bank Of Hawaii — FEI 2970043

The FDA completed an inspection of Blood Bank Of Hawaii on May 28, 2019 in Honolulu, HI. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
May 28, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Honolulu, HI (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.